Gene · 4172
Papers2,183
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,183
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Applications of Proteomics in Ovarian Cancer: Dawn of a New Era. | Proteomes | 2022 | 35645374 | PubTator, text mining | PubMed |
| High abundance of CDC45 inhibits cell proliferation through elevation of HSPA6. | Cell Prolif | 2022 | 35642733 | PubTator, text mining | PubMed |
| Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers. | Neuro Oncol | 2022 | 35639831 | PubTator, text mining | PubMed |
| Transcriptome Analysis and SNP Identification Reveal That Heterologous Overexpression of Two Uncharacterized Genes Enhances the Tolerance of Magnaporthe oryzae to Manganese Toxicity. | Microbiol Spectr | 2022 | 35638819 | PubTator, text mining | PubMed |
| UBE2S as a novel ubiquitinated regulator of p16 and β-catenin to promote bone metastasis of prostate cancer. | Int J Biol Sci | 2022 | 35637955 | PubTator, text mining | PubMed |
| A Motif-Based Network Analysis of Regulatory Patterns in Doxorubicin Effects on Treating Breast Cancer, a Systems Biology Study. | Avicenna J Med Biotechnol | 2022 | 35633986 | PubTator, text mining | PubMed |
| The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor. | Genes (Basel) | 2022 | 35627203 | PubTator, text mining | PubMed |
| Transcription Factor NRF2 Participates in Cell Cycle Progression at the Level of G1/S and Mitotic Checkpoints. | Antioxidants (Basel) | 2022 | 35624810 | PubTator, text mining | PubMed |
| The structural basis of Cdc7-Dbf4 kinase dependent targeting and phosphorylation of the MCM2-7 double hexamer. | Nat Commun | 2022 | 35614055 | PubTator, text mining | PubMed |
| Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling. | Nucleic Acids Res | 2022 | 35609998 | PubTator, text mining | PubMed |
| Hypomorphic GINS3 variants alter DNA replication and cause Meier-Gorlin syndrome. | JCI Insight | 2022 | 35603789 | PubTator, text mining | PubMed |
| Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma. | Front Genet | 2022 | 35601491 | PubTator, text mining | PubMed |
| STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment. | Br J Cancer | 2022 | 35595823 | PubTator, text mining | PubMed |
| MCM complexes are barriers that restrict cohesin-mediated loop extrusion. | Nature | 2022 | 35585235 | PubTator, text mining | PubMed |
| Fast and efficient DNA replication with purified human proteins. | Nature | 2022 | 35585232 | Swiss-Prot, curated | PubMed |
| Gene Expression Profiling of Glioblastoma to Recognize Potential Biomarker Candidates. | Front Genet | 2022 | 35571016 | PubTator, text mining | PubMed |
| Novel protein contact points among TP53 and minichromosome maintenance complex proteins 2, 3, and 5. | Cancer Med | 2022 | 35567389 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
| VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway. | J Transl Med | 2022 | 35562734 | PubTator, text mining | PubMed |
| Identification of potential prognostic biomarkers for hepatocellular carcinoma. | J Gastrointest Oncol | 2022 | 35557563 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4172/papers?page=19